Mario D’Andrea

2.9k total citations
54 papers, 1.8k citations indexed

About

Mario D’Andrea is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mario D’Andrea has authored 54 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 21 papers in Molecular Biology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mario D’Andrea's work include Colorectal Cancer Treatments and Studies (18 papers), Cancer therapeutics and mechanisms (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Mario D’Andrea is often cited by papers focused on Colorectal Cancer Treatments and Studies (18 papers), Cancer therapeutics and mechanisms (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Mario D’Andrea collaborates with scholars based in Italy, Canada and Spain. Mario D’Andrea's co-authors include Lara Maria Pasetto, Giuseppe Toffoli, S. Monfardini, Elena Rossi, Erika Cecchin, Elena De Mattia, Angela Buonadonna, Aldo Scarpa, Giuseppe Corona and Federico Innocenti and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Mario D’Andrea

52 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mario D’Andrea Italy	18	1.2k	857	231	230	162	54	1.8k
Gregory D. Leonard United States	13	1.4k 1.2×	517 0.6×	235 1.0×	286 1.2×	276 1.7×	30	2.0k
Tina Colombo Italy	25	910 0.8×	737 0.9×	295 1.3×	242 1.1×	102 0.6×	76	1.8k
Fabio Leonessa United States	16	884 0.7×	939 1.1×	98 0.4×	243 1.1×	91 0.6×	34	1.8k
Isrid Sturm Germany	24	1.1k 0.9×	1.2k 1.4×	216 0.9×	232 1.0×	232 1.4×	53	2.4k
Larry J. Schaaf United States	26	1.5k 1.3×	1.4k 1.6×	537 2.3×	132 0.6×	202 1.2×	89	2.8k
W J Nooijen Netherlands	19	1.3k 1.1×	528 0.6×	158 0.7×	187 0.8×	124 0.8×	29	1.9k
Danijela Jelovac United States	24	913 0.8×	921 1.1×	294 1.3×	465 2.0×	126 0.8×	51	2.2k
H J Broxterman Netherlands	21	1.7k 1.4×	1.2k 1.4×	185 0.8×	214 0.9×	269 1.7×	27	2.4k
Debra A. Tonetti United States	26	662 0.6×	935 1.1×	150 0.6×	245 1.1×	46 0.3×	57	1.7k
György Várady Hungary	23	989 0.8×	804 0.9×	154 0.7×	98 0.4×	156 1.0×	73	1.7k

Countries citing papers authored by Mario D’Andrea

Since Specialization

Citations

This map shows the geographic impact of Mario D’Andrea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario D’Andrea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario D’Andrea more than expected).

Fields of papers citing papers by Mario D’Andrea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario D’Andrea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario D’Andrea. The network helps show where Mario D’Andrea may publish in the future.

Co-authorship network of co-authors of Mario D’Andrea

This figure shows the co-authorship network connecting the top 25 collaborators of Mario D’Andrea. A scholar is included among the top collaborators of Mario D’Andrea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario D’Andrea. Mario D’Andrea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cereda, Vittore, et al.. (2024). Combination of the PARPi and ARSi in advanced castration resistant prostate cancer: a review of the recent phase III trials. SHILAP Revista de lepidopterología. 5(5). 997–1010. 1 indexed citations

Roncato, Rossana, Alessia Bignucolo, Elena Peruzzi, et al.. (2024). Clinical Benefits and Utility of Pretherapeutic DPYD and UGT1A1 Testing in Gastrointestinal Cancer. JAMA Network Open. 7(12). e2449441–e2449441. 7 indexed citations

Landi, Lorenza, Angelo Delmonte, Andrea Bonetti, et al.. (2022). Combi-TED: A new Trial Testing Tedopi ^® with Docetaxel or Nivolumab in Metastatic Non-Small-Cell Lung Cancer Progressing After First Line. Future Oncology. 18(40). 4457–4464. 2 indexed citations

Mattia, Elena De, Jerry Polesel, Rossana Roncato, et al.. (2021). IL15RA and SMAD3 Genetic Variants Predict Overall Survival in Metastatic Colorectal Cancer Patients Treated with FOLFIRI Therapy: A New Paradigm. Cancers. 13(7). 1705–1705. 8 indexed citations

Parcesepe, Pietro, Luigi Coppola, Andrea Remo, et al.. (2021). Molecular and Clinical Insights in Malignant Brenner Tumor of the Testis With Liver Metastases:A Case Report. Frontiers in Oncology. 11. 663489–663489. 4 indexed citations

Giordano, Guido, Pietro Parcesepe, Mario D’Andrea, et al.. (2019). JAK/Stat5-mediated subtype-specific lymphocyte antigen 6 complex, locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancer. Journal of Experimental & Clinical Cancer Research. 38(1). 28–28. 29 indexed citations

Lévesque, Éric, Erika Cecchin, Elena De Mattia, et al.. (2019). Germline variability and tumor expression level of ribosomal protein gene RPL28 are associated with survival of metastatic colorectal cancer patients. Scientific Reports. 9(1). 13008–13008. 10 indexed citations

Mattia, Elena De, Eva Dreussi, Marcella Montico, et al.. (2018). A Clinical-Genetic Score to Identify Surgically Resected Colorectal Cancer Patients Benefiting From an Adjuvant Fluoropyrimidine-Based Therapy. Frontiers in Pharmacology. 9. 1101–1101. 5 indexed citations

Mattia, Elena De, Erika Cecchin, Marcella Montico, et al.. (2018). Association of STAT-3 rs1053004 and VDR rs11574077 With FOLFIRI-Related Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients. Frontiers in Pharmacology. 9. 367–367. 16 indexed citations

10.

Garziera, Marica, Saverio Virdone, Elena De Mattia, et al.. (2017). HLA-G 3′UTR Polymorphisms Predict Drug-Induced G3-4 Toxicity Related to Folinic Acid/5-Fluorouracil/Oxaliplatin (FOLFOX4) Chemotherapy in Non-Metastatic Colorectal Cancer. International Journal of Molecular Sciences. 18(7). 1366–1366. 11 indexed citations

11.

Giordano, Guido, Massimo Pancione, Pietro Parcesepe, et al.. (2017). Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions. World Journal of Gastroenterology. 23(32). 5875–5875. 77 indexed citations

12.

Garziera, Marica, Ettore Bidoli, Erika Cecchin, et al.. (2015). HLA-G 3'UTR +2960 14-bp INDEL (Ins/Del) polymorphism is associated to improved DFS of stage II-III CRC patients. Annals of Oncology. 26. vi43–vi43. 1 indexed citations

13.

Garziera, Marica, Ettore Bidoli, Erika Cecchin, et al.. (2015). HLA-G 3’UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment. PLoS ONE. 10(12). e0144000–e0144000. 28 indexed citations

14.

Gasparini, Giampietro, Fiamma Buttitta, Mario D’Andrea, et al.. (2014). Optimizing Single Agent Panitumumab Therapy in Pre-Treated Advanced Colorectal Cancer. Neoplasia. 16(9). 751–756. 3 indexed citations

15.

Mattia, Elena De, Giuseppe Toffoli, Jerry Polesel, et al.. (2013). Pharmacogenetics of ABC and SLC transporters in metastatic colorectal cancer patients receiving first-line FOLFIRI treatment. Pharmacogenetics and Genomics. 23(10). 549–557. 45 indexed citations

16.

Cecchin, Erika, Mario D’Andrea, Sara Lonardi, et al.. (2012). A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen. The Pharmacogenomics Journal. 13(5). 403–409. 64 indexed citations

17.

Longo, Raffaele, Mario D’Andrea, Roberta Sarmiento, & Giampietro Gasparini. (2010). Pharmacogenetics in breast cancer: focus on hormone therapy, taxanes, trastuzumab and bevacizumab. Expert Opinion on Investigational Drugs. 19(sup1). S41–S50. 23 indexed citations

18.

Caricasole, Andrea, Chiara Costanzo, Daniela Diamanti, et al.. (2008). Identification of a candidate alternative promoter region of the human Bcl2L11 (Bim) gene. BMC Molecular Biology. 9(1). 56–56. 7 indexed citations

19.

Donadelli, Massimo, Chiara Costanzo, Stefania Beghelli, et al.. (2007). Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1773(7). 1095–1106. 132 indexed citations

20.

Pasetto, Lara Maria, Mario D’Andrea, Cristina Falci, & S. Monfardini. (2006). Gemcitabine in advanced biliary tract cancers. Critical Reviews in Oncology/Hematology. 61(3). 230–242. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact